bioAffinity Technologies, Inc.
BIAF- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.
Other share classesBIAFW
13F holders, Q2 2026
Institutional positions in bioAffinity Technologies, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +6 vs. Q1 2026
- Shares held
- 805.9K
- +563.7K (+232.7%) vs. Q1 2026
- Total value
- $782.5K
- −$146.0K (−15.7%) vs. Q1 2026
- New holders
- 10
- 4 more added
- Sold out
- 4
- 1 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $782.5K |
| Q1 2026 | 14 | $928.5K |
| Q4 2025 | 9 | $92.5K |
| Q3 2025 | 12 | $823.7K |
| Q2 2025 | 17 | $104.0K |
| Q1 2025 | 17 | $132.3K |
| Q4 2024 | 16 | $497.4K |
| Q3 2024 | 14 | $973.0K |
| Q2 2024 | 17 | $863.3K |
| Q1 2024 | 14 | $484.4K |
| Q4 2023 | 12 | $230.5K |
| Q3 2023 | 10 | $139.7K |
| Q2 2023 | 7 | $177.0K |
| Q1 2023 | 6 | $193.5K |
| Q4 2022 | 5 | $133.5K |
| Q3 2022 | 6 | $192.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding bioAffinity Technologies, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 3 | $2 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 833 | $676 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 931 | $1.00K | 0.00% | +931 | New |
| EMC Capital Management | 2,001 | $1.00K | 0.00% | +2,001 | New |
| UBS Group AG | 4,204 | $3.41K | 0.00% | −5,010−54.4% | Reduced |
| Tower Research Capital LLC (TRC) | 6,482 | $5.26K | 0.00% | +4,419+214.2% | Added |
| Allworth Financial LP | 10,000 | $8.12K | 0.00% | +10,000 | New |
| Parrish Capital LLC | 10,418 | $8.46K | 0.01% | +10,418 | New |
| Virtu Financial LLC | 11,113 | $9.00K | 0.00% | +11,113 | New |
| Northern Trust Corp | 16,748 | $13.6K | 0.00% | +4,023+31.6% | Added |
| HRT Financial LP | 20,834 | $16.0K | 0.00% | +20,834 | New |
| State Street Corp | 24,086 | $19.6K | 0.00% | +9,700+67.4% | Added |
| Jane Street Group, LLC | 26,784 | $21.7K | 0.00% | +26,784 | New |
| Susquehanna International Group, LLP | 26,870 | $21.8K | 0.00% | +26,870 | New |
| Vanguard Fiduciary Trust Co | 31,071 | $25.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 50,967 | $41.4K | 0.00% | +2,674+5.5% | Added |
| Vanguard Capital Management LLC | 55,543 | $45.1K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 98,777 | $80.2K | 0.00% | +98,777 | New |
| J. Safra Sarasin Holding AG | 42,600 | $164.0K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 365,647 | $296.9K | 2.47% | +365,647 | New |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −24,413−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |